B Cell Depletion Treatment in Resistant Systemic Sclerosis Interstitial Lung Disease

Mediterranean Journal of Rheumatology

article

Constantina A. Bounia¹  Stamatis-Nick C. Liossis¹ 

[1] Division of Rheumatology, Patras University Hospital;Department of Internal Medicine, University of Patras Medical School

关键词: systemic sclerosis;    interstitial lung disease;    B cell depletion;    rituximab;    pulmonary involvement;   

DOI  :  10.31138/mjr.33.1.1

学科分类：社会科学、人文和艺术（综合）

来源: PCO Convin S.A.

【 摘 要 】

Systemic sclerosis is a systemic, autoimmune disease that in many patients affects not only the skin, but also internal organs, mainly the lung. It is clear that internal organ (ie, lung) involvement determines the prognosis. Therefore, there is an unmet need to introduce novel and more effective treatments capable of halting disease progression and hence improve prognosis.

【 授权许可】

CC BY-NC